678. Point Prevalence Survey on Antimicrobial Use in Pediatric Post-acute Care Facilities
Session: Poster Abstract Session: Stewardship: Data and Program Planning
Thursday, October 5, 2017
Room: Poster Hall CD
  • IDWeek ABX in PLTCF.pdf (330.8 kB)
  • Background:

    Antimicrobial use data in adult nursing homes have been used to direct antimicrobial stewardship (AS) efforts for this healthcare setting. However, little is known about antimicrobial use in pediatric post-acute care facilities (pPACFs).  The purpose of this study was to describe antimicrobial use in pPACFs.


    We performed a point prevalence study of antimicrobial use in six geographically diverse pPACFs on two study dates: January 20 and July 20, 2016.  Eligible facilities cared for residents ² 21 years old. Collected data were extracted from residentsÕ medical records and included antimicrobial agents given on the 2 study days; the indication for use, categorized as treatment of an infection, non-infectious use, e.g., dysmotility, or prophylaxis; and route of administration. Chi-squared tests were performed as applicable; P values < 0.05 were considered statistically significant.


    On January 20, 10% (67/666) of residents received 82 antimicrobial agents of which 45% were given to treat an infection (Figure 1).  On July 20, 7% (49/677) of residents received 58 antimicrobial agents of which 51% were given to treat an infection.  Skin and soft tissue infections (SSTIs) were the most common infectious indication, accounting for 24% and 27% of residents given an antimicrobial for infection in January and July, respectively (Figure 2).   Respiratory tract infections (RTI) accounted for 3% of residents given an antimicrobial for infection in January compared to 16% in July (p<0.01). For treatment of infections, there was no significant difference between the use of systemic (oral and intravenous) agents in January (63%) compared to July (48%, p =0.2, Figure 3); cephalosporins (32%) were the most common agents used. In July, topical antimicrobials were more common (52%) of which mupirocin and clindamycin were most common. 


    In pPACFs, antimicrobial agents were less commonly given for infections than for non-infectious indications and prophylaxis. SSTIs were the most common infection and topical agents were more commonly used to treat infections in July. Surprisingly, treatment of RTIs was more common in July. This study suggests that care guidelines could be useful in promoting AS efforts for pPACFs.


    Candace L Johnson, MD1, Natalie Neu, MD MPH1 and Lisa Saiman, MD, MPH2, (1)Pediatrics, Columbia University Medical Center, New York, NY, (2)Pediatric Infectious Diseases, Coumbia University Medical Center, New York, NY


    C. L. Johnson, None

    N. Neu, None

    L. Saiman, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.